Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

24 trials with published results (16%)

Research Maturity

132 completed trials (88% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

2 terminated out of 150 trials

Success Rate

98.5%

+12.0% vs benchmark

Late-Stage Pipeline

21%

32 trials in Phase 3/4

Results Transparency

18%

24 of 132 completed with results

Key Signals

24 with results99% success

Data Visualizations

Phase Distribution

108Total
Not Applicable (34)
P 1 (16)
P 2 (26)
P 3 (20)
P 4 (12)

Trial Status

Completed132
Unknown11
Terminated2
Not Yet Recruiting2
Withdrawn1
Recruiting1

Trial Success Rate

98.5%

Benchmark: 86.5%

Based on 132 completed trials

Clinical Trials (150)

Showing 20 of 20 trials
NCT04983030Phase 1Active Not Recruiting

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

NCT05031819Not ApplicableCompleted

Managing Hypertension Among People Living With HIV

NCT02479698Phase 2RecruitingPrimary

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

NCT04772469Not ApplicableCompleted

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

NCT02639754Not ApplicableCompletedPrimary

Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria

NCT03746600Not ApplicableCompletedPrimary

Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS

NCT06280001Not Yet RecruitingPrimary

A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infection

NCT02396979Phase 4Completed

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

NCT01791556Not ApplicableCompletedPrimary

Clinic-based ART Diagnostic Evaluation

NCT05685641Not ApplicableUnknownPrimary

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

NCT02929069Not ApplicableCompleted

A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk

NCT00474370Phase 3Completed

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)

NCT05493969Phase 4Not Yet RecruitingPrimary

Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity

NCT01590017Phase 2Completed

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

NCT04122404Not ApplicableCompleted

POC Strategies to Improve TB Care in Advanced HIV Disease

NCT05225493Unknown

HIV Indicator Diseases in Hospital and Primary Care

NCT00000587Phase 2CompletedPrimary

Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

NCT04192487Phase 4CompletedPrimary

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

NCT01401348CompletedPrimary

Stanford Universities: The Stanford HIV Aging Cohort

NCT03583138Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Scroll to load more

Research Network

Activity Timeline